HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incomplete response to artificial tears is associated with features of neuropathic ocular pain.

AbstractAIMS:
Artificial tears are first-line therapy for patients with dry eye symptoms. It is not known, however, which patient factors associate with a positive response to therapy. The purpose of this study was to evaluate whether certain ocular and systemic findings are associated with a differential subjective response to artificial tears.
METHODS:
Cross-sectional study of 118 individuals reporting artificial tears use (hypromellose 0.4%) to treat dry eye-associated ocular pain. An evaluation was performed to assess dry eye symptoms (via the dry eye questionnaire 5 and ocular surface disease index), ocular and systemic (non-ocular) pain complaints and ocular signs (tear osmolarity, tear breakup time, corneal staining, Schirmer testing with anaesthesia, and eyelid and meibomian gland assessment). The main outcome measures were factors associated with differential subjective response to artificial tears.
RESULTS:
By self-report, 23 patients reported no improvement, 73 partial improvement and 22 complete improvement in ocular pain with artificial tears. Patients who reported no or partial improvement in pain with artificial tears reported higher levels of hot-burning ocular pain and sensitivity to wind compared with those with complete improvement. Patients were also asked to rate the intensity of systemic pain elsewhere in the body (other than the eye). Patients who reported no or incomplete improvement with artificial tears had higher systemic pain scores compared with those with complete improvement.
CONCLUSIONS:
Both ocular and systemic (non-ocular) pain complaints are associated with a differential subjective response to artificial tears.
AuthorsAnat Galor, Hatim Batawi, Elizabeth R Felix, Todd P Margolis, Konstantinos D Sarantopoulos, Eden R Martin, Roy C Levitt
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 100 Issue 6 Pg. 745-9 (06 2016) ISSN: 1468-2079 [Electronic] England
PMID26377416 (Publication Type: Journal Article)
CopyrightPublished by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Chemical References
  • Lubricant Eye Drops
  • Hypromellose Derivatives
Topics
  • Cross-Sectional Studies
  • Dry Eye Syndromes (complications, diagnosis, drug therapy)
  • Eye Pain (diagnosis, drug therapy, etiology)
  • Female
  • Follow-Up Studies
  • Humans
  • Hypromellose Derivatives (administration & dosage)
  • Lubricant Eye Drops (administration & dosage)
  • Male
  • Meibomian Glands (metabolism)
  • Middle Aged
  • Neuralgia (diagnosis, drug therapy, etiology)
  • Pain Measurement
  • Prospective Studies
  • Surveys and Questionnaires
  • Tears (metabolism)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: